Abstract
Employing a sensitive competitive protein binding assay for NSILA (non-suppressible insulin-like activity), circulating levels of this somatomedin (SM) have been measured throughout pregnancy, at parturition, and in foetal and newborn sera. Acid-dissociable serum NSILA (mean +/- SEM) in 57 women was significantly higher during pregnancy (1106 +/- 46 microunits/ml), than in 11 adult non-pregnant control subjects (844 +/- 22 microunits/ml), but not correlated with week of gestation or with serum growth hormone (GH) or cortisol levels. At parturition, the NSILA concentration in 28 cord sera (598 +/- 38 microunits/ml) was significantly less than in the corresponding maternal sera (1039 +/- 63 microunits/ml). The NSILA levels in 23 premature newborns (370 +/- 20 microunits/ml) and 8 small-for-gestational-age newborns (310 +/- 46 microunits/ml) were significantly less than in 33 term newborns (494 +/- 18 microunits/ml). Serum NSILA in 56 term and premature newborns exhibited a significant positive correlation both with gestational age and birth weight but not with serum GH or cortisol levels. These data suggest that the maternal-foetal growth-promoting system is a highly complex one in which NSILA levels both in maternal and foetal circulations appear to be under multifactorial control.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
